SS Innovations International (SSII) Shareholder's Equity Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.38% |
| Dec 31, 2025 | 153.39% |
| Sep 30, 2025 | 196.04% |
| Jun 30, 2025 | 238.23% |
| Mar 31, 2025 | 378.50% |
| Dec 31, 2024 | 184.30% |
| Sep 30, 2024 | 154.79% |
| Jun 30, 2024 | 167.86% |
| Mar 31, 2024 | 188.66% |
| Dec 31, 2023 | 191.19% |
| Sep 30, 2023 | 143.24% |
| Jun 30, 2023 | 43.03% |
| Mar 31, 2023 | -54.64% |
| Dec 31, 2022 | -36.07% |
| Sep 30, 2022 | 2.16% |
| Jun 30, 2022 | -19.34% |
| Mar 31, 2022 | 0.86% |
| Dec 31, 2021 | 66.62% |
| Sep 30, 2021 | -52.74% |
| Jun 30, 2021 | -194.65% |
| Mar 31, 2021 | -87.63% |
| Dec 31, 2020 | -119.64% |
| Sep 30, 2020 | -76.21% |
| Jun 30, 2020 | -38.55% |
| Dec 31, 2019 | -44.14% |